Search Results - "Hellmis, Eva"

Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial.

Authors: De Santis, Maria Palou Redorta, Joan Nishiyama, Hiroyuki et al.

Source: Lancet. Nov2025, Vol. 406 Issue 10516, p2221-2234. 14p.

Subjects: Non-muscle invasive bladder cancer, BCG immunotherapy, Treatment effectiveness, Adverse health care events, Progression-free survival, Immune checkpoint inhibitors, Clinical trials

This result is not displayed to guests.
Login for full access.

First-Line Treatment with Tivozanib for Metastatic Renal Cell Carcinoma in Real-World Settings Across Germany: Results of the Prospective, Non-Interventional, Post-Approval Study T-Rex.

Authors: Grünwald, Viktor Rußwurm, Karen Eckert, Ralf et al.

Source: Cancers. Dec2025, Vol. 17 Issue 24, p3910. 15p.

Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancer.

Authors: Boegemann, Martin Bennamoun, Mostefa Dourthe, Louis Marie et al.

Source: BMC Cancer. 7/1/2025, Vol. 25 Issue 1, p1-12. 12p.

Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Working Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass)

Authors: Grünwald, Viktor Ivanyi, Philipp Zschäbitz, Stefanie et al.

Source: European Urology. Dec2023, Vol. 84 Issue 6, p571-578. 8p.

Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma.

Authors: Sonpavde, Guru P. Sternberg, Cora N. Loriot, Yohann et al.

Source: European Journal of Cancer. Mar2022, Vol. 163, p55-65. 11p.

Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder: Results of a multicentre observational cohort study.

Authors: Alloussi, Schahnaz Mürtz, Gerd Braun, Reinhard et al.

Source: BJU International. Aug2010, Vol. 106 Issue 4, p550-556. 7p. 2 Charts, 2 Graphs.

[Update of S3 guideline on metastatic prostate cancer-guideline recommendations and expert consensus].

Transliterated Title: Aktualisierung S3-Leitlinie zum metastasierten Prostatakarzinom – Leitlinienempfehlungen und Expertenkonsens.

Authors: Grimm MO Gratzke C Hadaschik B et al.

Source: Urologie (Heidelberg, Germany) [Urologie] 2026 May; Vol. 65 (5), pp. 480-489. Date of Electronic Publication: 2026 Apr 13.

Publication Type: Journal Article; Practice Guideline; Review; Consensus Statement; English Abstract

Journal Info: Publisher: Springer Medizin Country of Publication: Germany NLM ID: 9918384886606676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2731-7072 (Electronic) Linking ISSN: 27317064 NLM ISO Abbreviation: Urologie Subsets: MEDLINE

Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01.

Authors: Azad AA Agarwal N Armstrong AJ et al.

Source: Future oncology (London, England) [Future Oncol] 2026 Apr; Vol. 22 (10), pp. 1153-1163. Date of Electronic Publication: 2026 Apr 14.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysis.

Authors: Yu EY Suzuki H Pieczonka CM et al.

Source: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2025 Nov 01. Date of Electronic Publication: 2025 Nov 01.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE

[Treatment of nonmetastatic CRPC : Androgen receptor inhibition as new treatment standard in nonmetastatic castration-resistant prostate cancer with high risk of metastasis].

Transliterated Title: Therapie des nicht-fernmetastasierten CRPC : Androgenrezeptorinhibition als neuer Therapiestandard beim nicht-fernmetastasierten kastrationsresistenten Prostatakarzinom mit hohem Metastasierungsrisiko.

Authors: Hadaschik B Hellmis E

Source: Der Urologe. Ausg. A [Urologe A] 2021 Jun; Vol. 60 (6), pp. 753-759. Date of Electronic Publication: 2021 Feb 11.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 1304110 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-0563 (Electronic) Linking ISSN: 03402592 NLM ISO Abbreviation: Urologe A Subsets: MEDLINE

Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial.

Authors: Ohlmann CH Jäschke M Jaehnig P et al.

Source: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2023 Dec; Vol. 26 (4), pp. 812.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE; PubMed not MEDLINE

[Prostate Cancer: Side-Effect Management for Androgen Deprivation Therapy].

Transliterated Title: Prostatakarzinom: Nebenwirkungsmanagement unter Androgendeprivationstherapie.

Authors: Hellmis E Mudra TN Merseburger AS

Source: Aktuelle Urologie [Aktuelle Urol] 2023 Sep; Vol. 54 (5), pp. 398-404. Date of Electronic Publication: 2023 Mar 27.

Publication Type: English Abstract; Journal Article

Journal Info: Publisher: Thieme Country of Publication: Germany NLM ID: 0421406 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1438-8820 (Electronic) Linking ISSN: 00017868 NLM ISO Abbreviation: Aktuelle Urol Subsets: MEDLINE

[Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program].

Transliterated Title: Apalutamid bei Patienten mit einem Hochrisiko-M0CRPC: Daten der Zulassungsstudie SPARTAN und erste Erfahrungen aus einem Härtefallprogramm.

Authors: Hellmis E Schwentner C Mandel P et al.

Source: Aktuelle Urologie [Aktuelle Urol] 2023 Apr; Vol. 54 (2), pp. 140-147. Date of Electronic Publication: 2021 Feb 23.

Publication Type: English Abstract; Journal Article

Journal Info: Publisher: Thieme Country of Publication: Germany NLM ID: 0421406 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1438-8820 (Electronic) Linking ISSN: 00017868 NLM ISO Abbreviation: Aktuelle Urol Subsets: MEDLINE

[Retrospective practice-related care research study on therapy of mCPRC with radium-223 dichloride].

Transliterated Title: Retrospektive Versorgungsstudie von d-uo zur Therapie des mCRPC mit Radium-223-dichlorid.

Authors: Jores C König F Hellmis E et al.

Source: Aktuelle Urologie [Aktuelle Urol] 2022 Dec; Vol. 53 (6), pp. 511-516. Date of Electronic Publication: 2022 Sep 27.

Publication Type: English Abstract; Journal Article

Journal Info: Publisher: Thieme Country of Publication: Germany NLM ID: 0421406 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1438-8820 (Electronic) Linking ISSN: 00017868 NLM ISO Abbreviation: Aktuelle Urol Subsets: MEDLINE

LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial.

Authors: Ohlmann CH Jäschke M Jaehnig P et al.

Source: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2022 Apr; Vol. 25 (4), pp. 778-784. Date of Electronic Publication: 2022 Apr 16.

Publication Type: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE

Sexual problems in males with epilepsy--an interdisciplinary challenge!

Authors: Hellmis E; Kometenplatz 29, 47179 Duisburg, Germany. eva.hellmis@gmx.de

Source: Seizure [Seizure] 2008 Mar; Vol. 17 (2), pp. 136-40. Date of Electronic Publication: 2007 Dec 26.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9306979 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1059-1311 (Print) Linking ISSN: 10591311 NLM ISO Abbreviation: Seizure Subsets: MEDLINE